Conventional photodynamic therapy (PDT) is often limited in treating solid tumors due to
hypoxic conditions that impede the generation of reactive oxygen species (ROS), which are …

Drug delivery systems (DDSs) for tumor treatment is a specialized method aimed at
transporting therapeutic substances, especially anticancer drugs, to specific target areas in …

For its vital role in maintaining cellular activity and survival, mitochondrion is highly involved
in various diseases, and several strategies to target mitochondria have been developed for …

The emerging field of photoredox catalysis in mammalian cells enables spatiotemporal
regulation of a wealth of biological processes. However, the selective cleavage of stable …

Lung cancer is the second most common malignant tumor worldwide. The problem of drug
resistance in lung cancer leads to treatment failure and recurrence in more than 90% of …

Engineering stimuli-responsive nanoplatforms for multimodal therapeutics to combat the
diversity, complexity, and heterogeneity of malignant tumors has emerged as a new …

Cellular senescence, a vulnerable state of growth arrest, has been regarded as a potential
strategy to weaken the resistance of tumor cells, leading to dramatic improvements in …

Photoactivable chemotherapy (PACT) using metallic complexes provides spatiotemporal
selectivity over drug activation for targeted anticancer therapy. However, the poor absorption …

Ruthenium (II) complexes containing diimine ligands have contributed to the development of
agents for photoactivated chemotherapy. Several approaches have been used to obtain …

Revascularization is crucial for treating myocardial infarction (MI). Nitric oxide (NO), at an
appropriate concentration, is recognized as an ideal and potent pro-angiogenic factor …